Insulin Aspart

GeriatricPediatric
  • TRADE NAMES: NovoLog (Novo Nordisk); NovoRapid (Novo Nordisk); Ryzodeg (Novo Nordisk)
  • INDICATIONS: Diabetes mellitus
  • CLASS: Hormone, polypeptide
  • HALF-LIFE: 81 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Alcohol, Atypical antipsychotics, Beta blockers, Clonidine, Corticosteroids, Danazol, Disopyramide, Diuretics, Epinephrine, Estrogens, Fibrates, Fluoxetine, Isoniazid, Isoniazid, Lithium salts, MAO inhibitors, Niacin, Octreotide, Oral Contraceptives, Pentamidine, Phenothiazine derivatives, Pramlintide, Propoxyphene, Salbutamol, Salicylates, Somatropin, Sulfonamide antibiotics, Terbutaline, Thyroid hormones

PREGNANCY CATEGORY: B

Ryzodeg is insulin aspart and insulin degludec; various forms of insulin are available - see other insulin profiles for reaction details.

Our database has 27 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
NAILS.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top